Access Statistics for Jo Seldeslachts

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Retrospective Evaluation of the GDF/Suez Merger: Effects on Gas Hub Prices 0 0 0 46 1 3 6 86
A Retrospective Study of State Aid Control in the German Broadband Market 0 0 1 21 0 6 7 42
A Retrospective Study of State Aid Control in the German Broadband Market 0 0 0 23 0 6 9 49
A Retrospective Study of State Aid Control in the German Broadband Market 0 0 0 22 2 10 16 53
A retrospective evaluation of the GDF/Suez merger: Effects on gas hub prices 0 0 0 55 0 6 8 71
Acquiring R&D Projects: Who, When, and What? Evidence from Antidiabetic Drug Development 0 2 3 13 4 17 24 37
Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development 0 1 2 2 1 7 12 14
Acquiring R&D projects: who, when, and what? Evidence from antidiabetic drug development 0 0 2 16 2 10 15 27
Are M&As Spurring or Stifling Innovation? Evidence from Antidiabetic Drug Development 0 1 27 27 4 18 55 55
Are M&As spurring or stifling innovation? Evidence from antidiabetic drug development 0 0 12 12 1 18 24 24
Collusion through Joint R&D: An Empirical Assessment 0 0 0 78 1 7 9 194
Collusion through Joint R&D: An Empirical Assessment 0 0 1 64 1 7 9 123
Collusion through joint R&D: An empirical assessment 0 0 0 167 3 7 9 226
Common Ownership Patterns in the European Banking Sector – The Impact of the Financial Crisis 0 0 0 8 0 4 5 15
Common Ownership and Market Entry: Evidence from Pharmaceutical Industry 0 0 0 61 1 10 13 267
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry 0 0 2 55 0 8 13 98
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry 0 0 0 60 3 12 21 244
Common Ownership in the US Pharmaceutical Industry: A Network Analysis 0 0 0 15 0 0 3 42
Common Ownership in the US Pharmaceutical Industry: A Network Analysis 0 0 1 22 0 8 11 73
Common Ownership: Europe vs. the US 0 0 1 6 3 8 12 20
Common ownership and market entry: Evidence from the pharmaceutical industry 0 0 0 17 0 9 12 98
Common ownership and market entry: Evidence from the pharmaceutical industry 0 0 0 98 2 8 13 123
Common ownership in the US pharmaceutical industry: A network analysis 0 0 0 13 2 10 14 44
Common ownership in the US pharmaceutical industry: A network analysis 0 0 0 15 1 4 8 28
Common ownership: Europe vs. the US 0 0 0 5 1 8 12 27
Effective European Antitrust: Does EC Merger Policy Generate Deterrence 0 0 0 44 2 9 11 77
Effective European Antitrust: Does EC Merger Policy Generate Deterrence 0 0 0 34 1 4 5 67
Effective European antitrust: Does EC merger policy generate deterrence? 0 0 0 1 0 1 4 41
How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? 0 0 0 45 0 6 14 229
How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? 0 0 0 57 2 6 7 170
Interactions Between Product and Labour Market Reforms 0 0 0 283 1 8 15 1,092
Merger Clusters during Economic Booms 0 0 0 100 0 3 4 395
Merger Failures 0 0 0 450 0 7 13 1,338
Merger failures 0 0 1 229 4 13 21 592
Mergers, Investment Decisions and Internal Organisation 0 0 0 192 3 7 9 479
Mergers, Investment Decisions and Internal Organisation 0 0 0 86 0 4 7 450
Mergers, Investment Decisions and Internal Organisation 0 0 1 6 0 5 8 79
Mergers, Investment Decisions and Internal Organisation 0 0 0 343 1 4 6 1,292
On The Stability of Research Joint Ventures: Implications for Collusion 0 0 0 68 0 3 4 227
On the Stability of Research Joint Ventures: Implications for Collusion 0 0 0 71 1 4 8 271
Ownership Diversification and Product Market Pricing Incentives 0 0 0 1 6 26 28 32
Ownership Diversification and Product Market Pricing Incentives 0 0 0 17 1 11 26 65
Ownership diversification and product market pricing Incentives 0 0 0 2 0 8 19 26
R&D Spillovers through RJV Cooperation 0 0 0 3 1 5 10 34
R&D Spillovers through RJV Cooperation 0 0 0 5 0 6 11 23
R&D Spillovers through RJV Cooperation 0 0 0 9 1 4 7 27
R&D Spillovers throught RJV Cooperation 0 0 0 18 0 17 22 69
Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 0 51 0 4 6 205
Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 0 48 3 15 17 210
Remedy for Now but Prohibit for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 0 69 2 7 9 285
Screening and Merger Activity 0 0 0 91 2 9 13 368
The Contingent Effect of Alliance Design on Alliance Dynamics and Performance: An Experimental Study 0 0 0 30 0 4 9 59
The Deterrence Effects of U.S. Merger Policy Instruments 0 0 0 32 1 4 5 145
The Deterrence Effects of U.S. Merger Policy Instruments 0 0 0 15 2 8 14 105
The Dynamics of Research Joint Ventures: A Panel Data Analysis 0 0 0 108 5 9 10 384
The Dynamics of Research Joint Ventures: A Panel Data Analysis 0 0 0 96 2 5 7 319
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 1 2 137 2 13 18 147
US and EU Secure Vaccine Production on Home Soil 0 0 0 13 0 0 2 52
USA und EU setzen auf lokale Impfstoffproduktion - Versorgungssicherheit im Fokus 0 0 0 3 0 1 3 27
What Clients Want: Choices between Lawyers' Offerings 0 0 0 13 1 3 8 59
What Clients want: Choices between Lawyers' Offerings 0 0 0 17 1 3 4 52
What clients want: Choices between lawyers' offerings 0 0 0 2 0 7 11 39
Total Working Papers 0 5 56 3,710 78 464 735 11,611
1 registered items for which data could not be found

Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Retrospective Evaluation of the GDF/Suez Merger: Effects on the Belgian Gas Hub 0 0 0 0 0 4 6 8
Ausbau der deutschen Grundbreitbandversorgung: Lehren aus der Vergangenheit mahnen zur Besonnenheit 0 0 0 4 0 1 5 25
Changes in Common Ownership of German Companies 0 0 2 53 0 10 15 189
Collusion Through Joint R&D: An Empirical Assessment 0 0 1 54 3 8 14 209
Common Ownership Patterns in the European Banking Sector—The Impact of the Financial Crisis1 0 2 2 3 0 5 7 10
Common Ownership and Market Entry: Evidence from the Pharmaceutical Industry 1 2 3 3 1 15 18 18
Common Ownership in the U.S. Pharmaceutical Industry: A Network Analysis 0 0 0 0 3 5 6 9
Deutschland muss seine Digitalstrategie überdenken, um den Anschluss nicht zu verlieren: Editorial 0 0 0 3 0 4 7 37
Diversification, Common Ownership, and Strategic Incentives 0 0 0 18 2 5 5 57
EFFECTIVE EUROPEAN ANTITRUST: DOES EC MERGER POLICY GENERATE DETERRENCE? 0 0 0 3 3 8 10 61
EU Competition Policy Enforcement Supports Investment in the Energy Sectors 0 0 0 4 1 5 10 41
EU-Regionalbeihilfen haben positiven Einfluss auf Investitionen 0 0 0 2 1 3 4 16
EU-Wettbewerbspolitik fördert Investitionen in den Energiesektoren 0 0 0 2 0 1 3 33
Effective European Antitrust: Does EC Merger Policy Generate Deterrence? 0 0 0 4 0 4 5 30
Endogenous mergers and endogenous efficiency gains: The efficiency defence revisited 0 0 0 87 1 9 14 284
Europeanization of EU member-state competition policy: The commission's leadership role 0 0 1 14 1 3 5 78
Harte Restriktionen scheinen die wirksamste Maßnahme zu sein, um in einer Pandemie den Flugverkehr zu beschränken: Interview 0 0 0 0 0 0 1 1
How to Measure the Deterrence Effects of Merger Policy: Frequency or Composition? 0 0 0 33 1 8 10 132
Learning dynamics in research alliances: A panel data analysis 0 0 0 32 4 8 13 236
Let’s Not Stick Together: Anticipation of Cartel and Merger Control in The Netherlands 0 0 0 20 0 3 4 91
Mandanten von Anwälten wollen kein Stundenhonorar 0 0 0 1 0 2 2 37
Mehr gemeinsame Anteilseigner, mehr US-Investoren: Eigentümerstrukturen deutscher Firmen haben sich verändert 0 0 0 2 0 1 3 11
Merger Failures 0 0 2 11 0 13 20 189
Nur harte Corona-Regeln wirken sich auf den Passagierflugverkehr zwischen Deutschland und Mallorca aus 0 0 0 1 0 2 3 7
On the Stability of Research Joint Ventures: Implications for Collusion 0 0 0 0 0 4 7 48
Only Strict Coronavirus Regulations for Vacationers Affect Passenger Air Traffic between Germany and Mallorca 0 0 0 0 0 2 3 14
Paying by the Hour: The Least Appealing Option for Clients of Lawyers 0 0 0 0 0 2 3 46
R&D Spillovers through RJV Cooperation 0 0 0 0 1 14 20 21
R&D spillovers through RJV cooperation 0 0 0 4 2 11 17 41
SCREENING AND MERGER ACTIVITY 0 0 0 0 2 8 11 100
SYNCHRONISING DEREGULATION IN PRODUCT AND LABOUR MARKETS 0 0 0 7 1 6 8 52
Schepping en vernietiging van banen: De invloed van O&O-actieve bedrijven 0 0 0 0 0 1 3 31
Settle for Now but Block for Tomorrow: The Deterrence Effects of Merger Policy Tools 0 0 1 49 1 9 15 199
The Deterrence Effects of US Merger Policy Instruments 0 0 1 19 3 10 16 135
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 0 0 3 0 9 13 37
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 0 0 0 2 11 14 14
The Impact of Competition Policy Enforcement on the Functioning of EU Energy Markets 0 0 1 2 0 6 10 12
The Pricing Structure of Legal Services: Do Lawyers Offer What Clients Want? 0 0 1 2 1 5 11 22
The political economy of mobile telecommunications liberalization: Evidence from the OECD countries 0 0 0 70 3 9 14 257
Transformational Strategies and Productivity Growth: A Transformational‐Activities Perspective on Stagnation in the New‐Normal Business Landscape 0 0 0 2 0 5 6 18
US-Vermögensverwalter gewinnen in Deutschland an Bedeutung: Interview 0 0 0 0 0 3 7 9
Veränderungen bei gemeinsamen Eigentümerstrukturen deutscher Unternehmen 0 0 0 3 0 1 2 19
Wichtig ist es, die Innovationseffekte der vielen Übernahmen zu berücksichtigen: Interview 0 0 0 0 0 1 2 3
Übernahmen in der Pharmaindustrie: Fokus mehr auf Innovationsmärkte als auf Marktverdrängung richten 0 0 0 1 0 2 2 8
Total Journal Articles 1 4 15 516 37 246 374 2,895
2 registered items for which data could not be found
logo

LogEc Home

Top Working Papers
Top Journal Articles
Top Books
Top Chapters
Top Software Items

Top Authors

Top Working Paper series and Journals

About LogEc

Authors with papers registered in the RePEc Author Service.

Register yourself as an author or register more papers in the RePEc Author Service.

Authors with no registered papers

RePEc
LogEc provides access and usage statistics for services based on the RePEc data set.

Örebro UniversityLogEc is hosted by the Örebro University School of Business.

Questions or comments? Please see our explanation of how the statistics are collected or e-mail

Since October 2025, abstract view statistics are potentially heavily influenced by traffic from AI bots and tools that we could not eliminate despite our best efforts.

Statistics updated 2026-03-04